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Abstract
Increasing evidence indicates that microRNAs (miRNAs), endogenous short non-coding RNAs 19–24 nucleotides in
length, play key regulatory roles in various biological events at the post-transcriptional level. Embryonic stem cells
(ESCs) represent a valuable tool for disease modeling, drug discovery, developmental studies, and potential
cell-based therapies in regenerative medicine due to their unlimited self-renewal and pluripotency. Therefore,
remarkable progress has been made in recent decades toward understanding the expression and functions of
specific miRNAs in the establishment and maintenance of pluripotency. Here, we summarize the recent knowledge
regarding the regulatory roles of miRNAs in self-renewal of pluripotent ESCs and during cellular reprogramming, as
well as the potential role of miRNAs in two distinct pluripotent states (naïve and primed).
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Background
MicroRNAs (miRNAs) are endogenous short non-
coding RNAs 19–24 nucleotides in length that regulate
gene expression at the post-transcriptional level [1]. The
first miRNA was identified in C. elegans by Lee and col-
leagues [2], who demonstrated that the lin-4 miRNA
downregulated the expression of the LIN-14 protein via
an antisense RNA-RNA interaction [2]. Since the term
miRNA was coined in 2001 [3], numerous miRNAs have
been identified in various organisms from plants to
mammals. Further, miRNAs are evolutionarily conserved
and are thus recognized as one of the essential regula-
tors in the control of many different processes including
development, homeostasis, and metabolism [4]. In
addition, aberrant miRNA expression is involved in sev-
eral diseases including cancer and chronic obstructive
pulmonary disease [5, 6]. Because each miRNA targets a
large number of mRNAs and multiple miRNAs can bind
to one specific mRNA, the potential impact of miRNAs
on the expression of a large number of proteins and on
transcriptome regulation is increasingly being investi-
gated to determine the crucial role of miRNAs in various
biological events.
Recent findings have revealed that molecular mecha-
nisms underlying the maintenance of embryonic stem
cell (ESC) pluripotency and cellular reprogramming have
been linked to miRNAs [1, 7]. ESCs are pluripotent cell
lines derived from the inner cell mass of blastocysts
[8, 9] and are characterized by two major properties that
define them: an unlimited self-renewal capacity in vitro
and pluripotency. Also, ESCs are able to form all three
germ layers and give rise to all cell types in the tissues of
the body [8, 9]. Due to these important properties, ESCs
represent a valuable tool for disease modeling, drug dis-
covery, developmental studies, and potential cell-based
therapies in regenerative medicine [10, 11]. A complex set
of intrinsic and extrinsic factors regulate the balance be-
tween self-renewal and lineage commitment in ESCs [12].
However, several aspects regarding the proliferation and
differentiation of ESCs at the post-transcriptional level re-
main unknown. Numerous studies have described the
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expression of unique clusters of miRNAs in ESCs includ-
ing miRNAs in the human and mouse miR-302 clusters,
the mouse miR-290 cluster, and the human miR-371 clus-
ter [7, 13]. It has been definitively predicted that miRNAs
may be a valuable means to regulate the proliferation and
the differentiation of ESCs. Here, we have reviewed the re-
cent discovery of miRNAs in ESCs and ESC-like stem cells
and their role in the regulation of self-renewal and during
cellular reprogramming.
Biogenesis and biological action of microRNAs
(miRNAs)
MiRNAss regulate gene expression at the post-
transcriptional level by binding to the 3′-untranslated
regions (3′ UTRs) or the open reading frames of target
genes, resulting in the degradation of target mRNA or
the inhibition of mRNA translation [1, 4]. MiRNAs rep-
resent ~4 % of the genes in the human genome and
regulate the expression of more than one third of the
protein-coding genes at the post-transcriptional level
[14]. Gene expression is controlled by mRNA sequestra-
tion, translation repression, or miRNA-mediated mRNA
decay [15]. Approximately half of miRNA genes are located
in intergenic regions and can be controlled from their own
promoters or as polycistronic clusters from a shared pro-
moter, whereas the remaining miRNAs are embedded
within protein-coding genes and are co-transcribed
with their host genes or from miRNA-specific promoters
[1, 4, 16]. Mature miRNAs are generated by multiple se-
quential endonucleolytic cleavage steps. The microproces-
sing complex consists of the RNAse III-like enzyme
Drosha and its cofactor DiGeorge syndrome critical region
gene 8 (DGCR8) [17–22]. Pre-miRNAs are further cleaved
by Dicer, an RNAse III enzyme, which gives rise to a
double-stranded RNA 22–24 nucleotide comprised of the
mature miRNA (guide strand) and the miRNA passenger
strand [23, 24]. Subsequently, the double-stranded mature
RNA with a less thermodynamically stable 5′-end (the
guide strand) is recruited by Argonaute proteins (AGOs)
and is loaded into the RNA-induced silencing complex
(RISC) to act as an miRNA [25, 26]. The RISC acts as an
effector that facilitates miRNA-dependent silencing via
binding of miRNAs to the 3′ UTR of the target mRNA
transcript based on complementarity between the miRNA
and the miRNA target. Nucleotides 2–8 (from the 5′ end)
of the mature miRNA (“seed region”) are crucial for target
identification, as perfect complementarity guides the
miRNA-induced degradation of the target mRNA through
AGO2 endonuclease activity [27, 28]. Partial pairing re-
sults in repression of the target mRNA translation at the
initiation step, or in sequestration of the target mRNAs
into cytoplasmic processing bodies, which happens by en-
gaging poly(A) nucleases to degrade mRNA through dead-
enylation pathways [29].
Embryonic stem cell (ESC)-specific microRNAs
(miRNAs)
The molecular basis of miRNAs for mouse ESCs (mESCs)
was initially demonstrated in mESCs lacking Dicer and
Dgcr8 [30–32]. Although Dicer- or Dgcr8-deficient
mESCs are viable, Dicer or Dgcr8 loss compromises the
biogenesis of miRNA and causes severe defects in the pro-
liferation and differentiation of mESCs. Furthermore,
Dicer- and Dgcr8-deficient mESCs fail to generate detect-
able teratomas and chimeric mice when subcutaneously
injected into nude mice and into blastocysts [30, 33].
These findings demonstrated the importance of miRNA
synthesis in mESC pluripotency and during early embry-
onic development [34].
In parallel with studies on the role of essential factors
for miRNA biogenesis in ESCs, the identification of
ESC-specific miRNAs has been explored in mESCs and
human ESCs (hESCs) to understand the post-
transcriptional regulation of genes related to the self-
renewal and pluripotency of ESCs [34]. Several tech-
niques including cloning, qPCR, microarray, and deep
sequencing have been employed to examine the expres-
sion of miRNAs in undifferentiated ESCs and their dif-
ferentiated counterparts. Interestingly, only a few ESC-
enriched miRNAs are transcribed and are unique to
ESCs, whereas other miRNAs are widely expressed but
decrease dramatically during differentiation. Thus, ESCs
are comprised of a unique set of ESC-specific miRNAs
[7, 35–37].
A large portion of these ESC-specific miRNAs consti-
tute two clusters: the miR-290 cluster in mice and their
human homologs in the miR-371-373 family and the
miR-302-367 cluster in both mice and humans [7]. Later,
Suh et al. identified several novel miRNAs from an un-
differentiated human ESC cDNA library belonging to
the miR-302 and miR-371 clusters [13]. In comparison
with Houbaviy’s data set, there are three common miR-
NAs (miR-296, miR-301, and miR-302) between the
mESCs and hESCs data sets. Taken together, these find-
ings strongly suggest that combinatorial regulation of
ESC-specific miRNAs and their target networks plays a
critical role in the maintenance of ESC pluripotency and
in the regulation of early embryonic development.
Role of embryonic stem cell (ESC)-specific
microRNAs (miRNAs)
Substantial evidence has shown that the miRNAs clus-
ters miR-302, miR-209, and miR-371 represent key regu-
lators of pluripotent stem cells [34, 38]. All of these
miRNAs clusters play critical roles in cellular processes,
such as maintaining pluripotency, proliferation, and dif-
ferentiation, which are the characteristics of stemness.
Recent findings suggest that ESC-specific transcription
factors regulate ESC-specific miRNAs and, in turn, these
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miRNAs control transcription factors, suggesting that
ESC-specific miRNAs are an essential and integral part
of the ESC dynamics [34, 39]. Furthermore, several re-
ports of functional investigations related to expression
and inhibition of miRNAs in ESCs suggest that miRNAs
are one of the key factors that control stemness in ESCs
[40, 41]. This applies to ESCs in which miRNAs might be
used as a tool to control proliferation and differentiation.
Function of miR-302 cluster members
The high degree of homology, regulation by ESC-specific
transcription factors, conservation of genomic loci, and cell
type-specific expression could be the basis for the func-
tional conservation of the miR-302 cluster in ESCs. The
ESC cell cycle is significantly shorter than that of somatic
cells, due largely to an abbreviated G1 phase [42]. In terms
of cell cycle regulation, the ectopic expression of individual
miR-302 members in both primary and transformed cell
lines leads to a decrease in the proportion of cells in the G1
phase and an increase in the proportion of cells in the S
phase by the inhibition of Cyclin D1 translation, which is a
G1 phase regulator. This evidence suggests that Cyclin D1
might be targeted by multiple members of the miR-302
cluster, and that one of the primary functions of miR-302 in
ESCs is cell cycle regulation [43].
For the maintenance and differentiation of ESCs, miR-
302b indirectly regulates Oct4 and directly targets Cyclin
D2, which is an important developmental regulator dur-
ing gastrulation, suggesting that miR-302b participates
in maintaining the pluripotency of embryonic carcinoma
cells (ECCs) [44]. Prior reports have indicated that the
TGF-β/Nodal signaling pathway is critical to the main-
tenance of pluripotency in hESCs [45, 46]. Lefty1 and 2,
which belong to the TGF-β/Activin/Nodal family and
act as primary antagonists of Nodal signaling, were
negatively regulated at both the transcriptional and
translational levels by miR-302-367 [47]. Thus, the ec-
topic expression of miR-302-367 might act as upstream
regulators of the TGF-β/Nodal signaling pathway via
Smad-2/3 signaling, leading to a delay in early hESC dif-
ferentiation and facilitating the maintenance of pluripo-
tency in hESCs [48]. Lipchina et al. identified several
putative targets of miR-302-367 in hESCs by genome-
wide screening processes, which suggested that this
miRNA cluster is a positive regulator of pluripotency
[49]. Other studies showed that miR-302-367 is capable
of regulating bone morphogenetic protein (BMP) signal-
ing in hESCs during neural differentiation [50], and that
the inhibition of this cluster leads to reduced efficiency
of BMP-dependent trophectoderm induction, which sug-
gests that miR-302-367 acts as a positive regulator of
BMP signaling [49, 51]. Recently, miR-302 cluster-silenced
mouse embryos exhibited defects in neural differentiation
by inhibition of neural progenitor expansion and precocious
differentiation [52]. In regards to reproduction, Scheel et al.
identified the miR-302 cluster as a potential suppressor of
p63 accumulation in various cell types by running a func-
tional screen utilizing a large miRNA expression library.
The mRNA and protein expression levels of p63 were re-
duced by miR-302 via two target sites within the 3′ UTR.
In addition, miR-302 displayed regulatory mechanisms for
p63 in germ cells by suppressing p63 in testicular cancer
cells and eliminating p63 mRNA in mature oocytes [53].
Function of miR-290 cluster
Members of the miR-290 cluster are the most highly
expressed miRNAs in mESCs comprising more than 60–
70 % of the total miRNAs expressed and are studied ex-
tensively in various backgrounds [54] including DNA
methylation, maintenance of pluripotency, germ cell de-
velopment, and generation of induced pluripotent stem
cells (iPSCs) [55, 56].
It was demonstrated that the miR-290 cluster was in-
volved in silencing the expression of Rbl2, which acts as a
transcriptional repressor of the DNA methyltransferase
(Dnmt) 3a and Dnmt3b enzymes. Further, Dnmt3a and
Dnmt3b enzymes, along with miRNAs, are downregulated
in Dicer1−/− cells [57]. Another research group showed a
mechanistic connection between members of the miR-290
group and de novo DNA methylation in ESCs, providing a
clue that these miRNAs are involved in the epigenetic con-
trol of gene expression. This de novo DNA methylation is
defective in Dicer1-deficient ESCs, which is consistent with
the indirect control of Dnmt expression by the miR-290
cluster [56]. Meanwhile, the miR-290 cluster inhibits the ar-
rest of ESCs in the G1 phase by suppressing several key reg-
ulators of the G1-S transition, thus accelerating cell
proliferation by promoting the G1 to S phase transition
[58]. Additional research on cell cycle dynamics has shown
that miR-290 and let-7 miRNAs have opposing effects
on ESC characterization of self-renewal and pluripotency
[59–61]. It is assumed that these two miRNA clusters ex-
hibit a feedback regulatory cycle, which allows a quick ex-
change mechanism between self-renewal and differentiation
of ESCs. The necessity for miRNA biogenesis during prim-
ordial germ development and early spermatogenesis was
established by the demonstration of increased expression of
miR-290 cluster members in male germline cells [62]. It
was reported that Dgcr8−/− ESCs failed to differentiate into
germ layers, and the expression levels of pluripotent marker
genes including Oct4, Sox2, and Nanog were increased in
Dgcr8-deficient ESCs, indicating that these pluripotent
markers are indeed in control of miRNAs [63]. In addition,
the miR-290 cluster showed some evidence of Wnt signal-
ing regulation by repressing the Wnt pathway inhibitor
Dkk-1 and by preventing ES cell differentiation to meso-
derm and germ cells in vitro [64]. In a loss-of-functional
study, the partial lethality phenotype was observed in
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embryos with a homozygous loss of the miR-290–295
locus that also resulted in infertility among female survi-
vors, suggesting that some of the members could be
responsible for the maintenance of pluripotency [65].
Recently, Kanellopoulou et al. suggested that one of the
miR-290 families of miRNAs (miR-291) regulates ESC
homeostasis by silencing polycomb-mediated gene expres-
sion via targeting methlytransferase Ash1l in ESCs [66].
Function of miR-371 cluster
MiR-371 is an orthologous human cluster of the mouse
miR-290 family (miR-290-295) that is preferentially
expressed in hESCs and that decreases rapidly in expres-
sion after differentiation [13, 37]. Although the contribu-
tions of this miRNA cluster to gene expression
programs in pluripotent stem cells have not been fully
elucidated, Cao et al. recently reported that miR-290/371
promotes pluripotency by regulating glycolytic metabol-
ism via the Mbd2-Myc signaling pathway in mouse and
human ESCs [67]. Furthermore, this miRNA cluster is
one of the ESC-specific miRNA clusters, but a few re-
ports have also described the involvement of miR-371 in
the regulation of embryonic cell carcinoma (ECC) and
tumorigenesis [68]. The expression of the miR-372/373
cluster was observed in subsets of ECC lines including
Tera1, 2102Ep, and 833KE, but not in NT2 and NCCIT
cell lines [69], which were correlated with the expression
of the miR-372/373 cluster and p53 status in these ECC
lines, based on low-level wt-p53 expression in NT2 cells
and single mutated alleles in NCCIT lines. In light of
these results, it was suggested that miRNAs in the miR-
372/373 cluster contribute to tumorigenesis in cells that
contain wt-p53 [69]. It has been demonstrated that cis-
platin represses the oncogenic properties of the miR-
372/373 group [70] and that miR-373 and miR-520 trigger
migration and invasion of cancer cells in vitro and in vivo
[71]. In regards to gain-of-functional studies, the over-
expression of miR-373 instantly induced the expression of
the E-cadherin and cold-shock domain-containing protein
C2 (CSDC2) genes, and the induction was specifically
dependent on the presence of both miR-373 and the pro-
posed target sites of miR-373 within the promoter region
of the E-cadherin and CSDC2 genes [72].
Potential roles of microRNAs (miRNAs) in naïve or
primed pluripotency
In mouse, ESCs are derived from the inner cell mass
(ICM) of blastocysts (naïve mESCs) and have different
characteristics in gene expression profiles, signaling
pathways for maintaining pluripotency, and in the devel-
opment potential compared to primed mESCs derived
from the epiblast of post-implantation embryos
(mEpiSCs) [73–77]. In human, ESCs are established
from the ICM of preimplantation blastocysts, but these
hESCs more closely resemble primed mESCs (mEpiSCs)
than naïve mESCs when assessed based on the charac-
teristics mentioned above [78–80]. In addition, mouse
and human induced pluripotent stem cells (iPSCs) de-
rived by introducing transcription factors into somatic
cells have been shown to have the same characteristics
as primed ESCs [81].
Regarding the link between pluripotent states (naïve or
primed) and microRNAs, the miR-290/295 cluster is a
major miRNA in mouse ICM and ESCs [82] and upon
implantation, expression of miR-302/367, miR-25/106b,
miR-17/92a, and miR-106a/363 clusters is restricted to
epiblasts [83]. In addition, the miR-20, miR-92, and miR-
302 miRNA seed families regulate primed pluripotent
stem cell survival via targeting the pro-apoptotic protein
BIM [83]. Expression of the miR-302/367 cluster is
enough to drive the reprogramming of murine and hu-
man somatic cells to a naïve or primed pluripotency in
the absence of exogenous key transcription factors [84].
Jouneau et al. reported that mESCs and mEpiSCs exhibit
a different miRNA expression profile with a different set
of pluripotent-associated miRNAs by deep sequencing of
small RNA libraries from three primed mEpiSCs and
two naïve mESCs. Also, this report indicate that 302 of
987 mature miRNAs are differentially expressed in each
pluripotent stem cell state, and among them, miR-302d,
miR-34c, miR-367, and let-7e are more highly expressed
in EpiSCs, whereas miR-294 and miR-142-3p are prefer-
entially expressed in mESCs. The five members of the
miR-200 family (miR-200a, miR-200b, miR-200c, miR-
141, and miR-429) are expressed in mESCs and downreg-
ulated during epithelial-mesenchymal transition or EMT.
Further, expression of miR-200c/141 suspends the differ-
entiation of mESCs in an EpiESC-like state [85].
In human pluripotent stem cells, miR-302b, miR-372,
miR-518b, miR-520b, and miR-520c are expressed in hu-
man primed pluripotent ESCs, and the primate-specific
chromosome 19 miR cluster (miR-518b, miR-520b, and
miR-520c) is expressed in primed state pluripotent cells
but declines upon differentiation [37, 86]. In addition,
miR-302b is a positive control for naïve and primed hu-
man pluripotent stem cells, whereas miR-518, miR-520b,
and miR-520c are upregulated during a shift to an earlier
pluripotency state [87]. Recently, Zhang et al. reported
that porcine-induced pluripotent stem cells (piPSCs)
were established by manipulating the culture conditions
(treatment of LIF, FGF2, and BMP4 with 2i (CHIR99021
and SB431542)). Zhang et al. also reported that these in-
duced cells exhibited mixed miRNA profiles, including
upregulation of the miR-302b/367 and miR-106a/363
clusters, and downregulation of let-7 family members
and the miR-17/92 cluster [88].
Although there are several reports that include the ex-
pression profiles of miRNAs in naïve and primed
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pluripotent stem cells, studies examining the functional
roles of these miRNAs that make distinctions between
naïve and primed pluripotent stem cells have not been
performed satisfactorily. Therefore, the physiological
roles of miRNAs in regulating pluripotent stages need to
be determined.
Importance of microRNAs (miRNAs) related to
induced pluripotency
Somatic cells could be transformed to iPSCs through
epigenetic reprogramming by ectopic expression of key
transcription factors [81]. However, genomic modifica-
tions due to random insertions of exogenous DNA into
the host genome remain a concern. To address this con-
cern, several research groups have tried to generate
iPSCs from somatic cells using PiggyBac transposons,
episomal systems, or proteins or mRNAs [89–93], but
these methods were technically challenging due to the
low efficiency of the processes for inducing pluripotency.
Recently, miRNAs have been used to reprogram pri-
mary somatic cells toward pluripotent cells [41, 94–97].
Further, ESC-specific miRNAs that are preferentially
expressed in ESCs and are known to be involved in the
control of pluripotent-related factors were identified.
The ESC-specific miR-302 family, which is composed of
five members, miR-302a/b/c/d and miR-367, is highly
expressed in undifferentiated mESCs, hESCs, and iPSCs,
but suppressed in differentiated cells [98]. MiR-302 reg-
ulates the expression of the pluripotency markers Oct4,
Sox2, Nanog, and SSEA-3/4 [99] and stimulates somatic
cell reprogramming, which results in the generation of
iPSCs through DNA demethylation and by downregula-
tion of Dnmt1 [98] and methyl-DNA binding domain
protein 2 (MBD2) [100]. In addition, miR-302 facilitates
mesenchymal to epithelial transition or MET via targeting
of the transforming growth factor β receptor II (TGFBR2)
and the Ras homolog gene family member C genes [95].
Recently, Zhang et al. reported that knockout of the miR-
302/367 cluster completely blocks human iPSC generation
from human foreskin fibroblasts [101]. Therefore, the
miR-302 family plays important roles in the reprogram-
ming of somatic cells for iPSC generation. Further, several
miRNAs enhance genomic reprogramming to induce
iPSCs by combined expression with key transcription
factors (Oct4, Sox2, Klf4, and Myc; OSKM) [102]. The
miR-290 family (miR-371 in humans) plays essential roles
during the reprogramming progress. Mir-291-3p, miR-
294, and miR-295 (miR-290 family) have been shown to
increase the efficiency of reprogramming by OSK and
ectopic expression of this cluster improves OSKM- or
OSK-reprogramming by inhibition of the TGF-β receptor
signaling [94–96, 102].
Reprogramming technologies are thought to be one of
the solutions for treating many age-associated diseases;
thus, several research groups are attempting to cure dis-
eases using iPSCs [103]. For example, despite the high
resistance to reprogramming apparent in old cells or tis-
sues, Sharma et al. reported that over-expression of Sir-
tuin 6 (SIRT6), which is one of the miR-766 targets in
aged human dermal fibroblasts, increases iPSC gener-
ation efficiency through the control of miR-766 tran-
scription via feedback regulation [104]. Wang et al.
found that Oct4 or Sox2 bind at the promoter region of
members of the miR-200 family of miRNAs, and that
these miRNAs help Oct4/Sox2 induce somatic cell re-
programming in the early stage by direct inhibition of
zinc finger E-box binding homeobox 2 (ZEB2) [105].
Members of the miR-200 family are also involved in the
regulation of EMT induction as well as MET [106–108].
In addition, epigenetic regulation of the miR-200 family
results in the conversion of a non-stem to a stem-like
cell by the loss of their expression [109]. The miR-181
family consists of four miRNAs (miR-181a, miR-181b,
miR-181c, and miR-181d) and these miRNAs act as
tumor suppressors in human malignant glioma [110] or
as activators of carcinogenesis in hepatic cancer, blood
cancers, and breast cancer [111–116]. In terms of cell
differentiation, members of the miRNA-180 family of
miRNAs inhibit the differentiation of hematopoietic cells
to mature cells via p27 targeting [117, 118]. Interestingly,
the miR-180 family of miRNAs is upregulated following
the introduction of key pluripotency factors (Oct4, Sox2,
and Klf4) and target several signaling molecules (Lin7c,
Tox, Bptf, Marcks, etc.), which results in the enhanced
generation of iPSCs [119]. Also, several studies have
shown that the expression profiles of miRNAs were dif-
ferent in hESCs, iPSCs, differentiated cells, and cancer
cells [120–122], which provides us with the fundamental
knowledge for developing another way to induce iPSCs
using preferentially expressed miRNAs without genomic
modification.
It is well known that p53 is a reprogramming barrier
for iPSC generation [123–126] and that several p53-
related miRNAs were identified as modulators or media-
tors of iPSC generation. The p53 signaling pathways are
regulated by mir-21 and -29b, and Sox2 regulates miR-
29b expression, which suppresses DNA methylation-
related reprogramming events (e.g., MET and Dlk1-Dio3
region transcription), resulting in enhanced iPSC gener-
ation [127, 128]. MiR-34 is one of the p53 targets that
contributes to p53 repression of iPSC generation and
that exhibits p53-dependent stimulation during repro-
gramming [129]. The depletion of miR-34 results in suc-
cessful iPSC generation without compromising cell
dynamics; therefore, miR-34 plays a crucial role in inhi-
biting somatic reprogramming. As targets of p53, miR-
92 and miR-141 have distinguishable expression profiles
in hESCs and iPSCs, and they provide two distinct
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pluripotency categories irrespective of the cell origin
[121]. Finally, miR-138 directly targets the 3′ UTR of
p53, resulting in suppression of p53 expression and its
downstream genes, and significant improvement in iPSC
generation [130]. Furthermore, the miR-17-92, miR-
106b-25, and miR-106a-364 clusters are highly induced
in the early stages of somatic cell reprogramming and
directly target p21 and TGFBR2, resulting in enhanced
iPSC generation by accelerating MET, cell cycle transi-
tions, and regulation of epigenetic factors [94, 96].
Here, we summarized the interaction of miRNAs with
their targets in DNA methylation, MET, and the cell
cycle for somatic cell reprogramming (Table 1). Al-
though pluripotency transcription factors are known to
bind at several regulatory regions for miRNA transcrip-
tion, or to inhibit their expression during somatic cell
reprogramming, the precise mechanisms by target genes
of these miRNAs remain unknown and require add-
itional study for high efficiency iPSC generation and
their clinical applications in the future.
Conclusions
Increasing evidence suggests that miRNA regulation and
function in pluripotent stem cells and somatic cell re-
programming is vital for the advancement of regenera-
tive medicine. Over the past decade, a large number of
miRNAs have emerged as pivotal components of a com-
plex molecular network of gene expression related to the
pluripotent cell state (Fig. 1).




miR-200s Stimulation ZEB2 [105]





miR-29b Stimulation Dnmt3a and 3b [127, 128]
miR-17-92, Stimulation Tgfbr2, p21 [94, 96]
miR-106b-25,
miR-106a-364
miR-138 Stimulation P53 [130]





miR-367 Pten, RhoC, Tgfbr2
miR-766 Inhibition SIRT6 [104]
miR-21 Inhibition P85α, Spry1 [128]
miR-34a Inhibition Nanog, Sox2,
N-myc
[129]
Fig. 1 Functions of microRNAs (miRNAs) in embryonic stem cell (ESC) self-renewal, differentiation, and cellular reprogramming. ESC-specific miRNAs
are involved in the maintenance and differentiation of ESCs by regulating key pluripotency factors (Oct4, Sox2, and Nanog), signaling molecules, and
cell cycle distribution. Furthermore, these miRNAs play important roles in somatic cell reprogramming to gain pluripotency via epigenetic regulations
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First, can any new miRNAs be identified? Emerging
advancements such as deep sequencing can be utilized
to predict many new miRNAs in pluripotent stem cells.
The new methods can likewise help us to directly profile
the activities between miRNAs and mRNAs. Second,
what is the best possible prerequisite miRNA dose for
regulation of pluripotency? Discovering specific miRNA
dosages might provide a possible mechanism for opti-
mizing and standardizing final gene products and in-
duced pluripotent products. Third, do mouse miRNAs
and human miRNAs possess the same functions? Des-
pite these open-ended questions, several studies have
shown that mouse and human cell science share a great
deal of similarities and that mESCs and hESCs exhibit
contrasting differences in the regulation of pluripotency
and further maintenance of stemness. Moreover, it is
understood that hESCs are more like epiblast stem cells
compared with mESCs, whereas mESCs are more
“embryonic” than their human counter-partner [131].
Regardless of their indistinguishable characteristics,
these reasons compel us to focus on mouse miRNAs
and their human counterparts.
Altogether, there are numerous different classes of
non-coding RNAs that may likewise assume a role in
managing pluripotency and differentiation. One may
speculate that miRNAs are involved in the fine-tuning of
their targets instead of in the regulation of on/off deci-
sions. This is because knockout of a single miRNA does
not typically affect embryonic development. One of the
reasons could be that a particular miRNA might be
compensated for by family members due to high se-
quence homology. Taken together, intensive screening
for targets that are regulated by miRNAs in hESCs, as
well as superior insight into the regulatory and func-
tional strategies for controlling hESC self-renewal, differ-
entiation, and iPSC generation is needed before these
pluripotent stem cells can be put into clinical practice.
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